I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilim..:
Blas, Leandro
;
Shiota, Masaki
;
Tsukahara, Shigehiro
...
Clinical Genitourinary Cancer. 22 (2024) 1 - p. e122-e127.e1 , 2024
Link:
https://doi.org/10.1016/j.clgc.2023.09.003
RT Journal T1
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus Nivolumab
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.clgc.2023.09.003&Exemplar=1&LAN=DE A1 Blas, Leandro A1 Shiota, Masaki A1 Tsukahara, Shigehiro A1 Nagakawa, Shohei A1 Matsumoto, Takashi A1 Eto, Masatoshi PB Elsevier BV YR 2024 SN 1558-7673 JF Clinical Genitourinary Cancer VO 22 IS 1 SP e122 OP e127.e1 LK http://dx.doi.org/https://doi.org/10.1016/j.clgc.2023.09.003 DO https://doi.org/10.1016/j.clgc.2023.09.003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)